This Series paper supports SDGs 3 and 10 by summarising the state of knowledge on inequalities in care delivery and outcomes for patients with cardiovascular disease in the UK

Standard methodology to detect antimicrobiological resistance genes can help in monitroing and hopefully preventing antimicrobial resistance and improving health.

Environmental pollution has negative health effects and biomonitoring is necessary to identify the regions, local sources, and temporal distribution of air pollution. The aim of this study was the estimation of cell viability, oxidative stress, DNA damage, cell cycle alterations and activation of histone H2A.X. Evidence is shown that γH2A.X may serve as a marker for monitoring the risk of air pollutant exposure.

This Article supports SDG 3 by estimating the burden of rheumatoid arthritis. Finding include that the rate of years lived with disability due to rheumatoid arthritis increased by 13.8% from 1990 to 2020. The authors note that outcomes including severity of disability can be improved by early diagnosis and access to DMARD therapy.

This article ties with climate action and reproductive medicine, as it is a reflexion on healthcare carbon footprint especially the IVF laboratories.

This article supports SDG 3 by assessing the changes in mortality rate and years of life lost associated with dementia attributable to high BMI in China. The findings suggest a rapid increase in dementia burden attributable to high BMI.

This Article supports SDG 3 by showing, through a modelling analysis, that community tenofovir, lamivudine, and dolutegravir (TLD) is likely to reduce HIV incidence and be cost-effective, thus leading to population health benefits.

WHO recommends dolutegravir as the preferred anchor drug for first-line and second-line HIV treatment, and is being rolled out globally. This study shows that dolutegravir is safe but clinicians should nonetheless be aware of the risk of psychiatric manifestations in children and adolescents taking the drug.

This Article supports SDG 3 by showing that interventions and strategies to reduce mortality from HIV-related CNS infection in public hospitals within routine care services can substantially reduce all-cause 2-week mortality among people living with HIV presenting to public hospitals with suspected HIV-related CNS infection.